Cardiome Pharma Corp (NASDAQ:CRME)

2.37
Delayed Data
As of 12:06pm ET
 +0.0003 / +0.01%
Today’s Change
1.29
Today|||52-Week Range
4.84
+52.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues30.0M20.9M25.3M24.0M
 
 
 
 
 
Cost of Goods Sold10.0M6.6M6.3M6.8M
 
 
 
 
 
Depreciation And Amortization2.2M2.2M3.0M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income17.9M12.1M16.0M13.7M
 
 
 
 
 
General Expenses34.5M34.2M30.5M36.7M
 
 
 
 
 
Research And Development637.0K3.2M0.000.00
 
 
 
Total Operating Expenses46.6M43.0M39.8M47.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.6M-22.1M-14.6M-23.0M
 
 
 
 
 
Extraordinary Charge0.000.00-1.4M-1.5M
 
 
 
Interest Expense On Debt1.5M2.3M2.5M5.7M
 
 
 
 
 
Other Expenses-110.0K-132.0K-971.0K677.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.2M-24.5M-19.5M-29.4M
 
 
 
 
 
Income Taxes-49.0K-11.0K-152.0K-363.0K
 
 
 
 
 
Net Income-18.2M-24.5M-19.6M-29.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.2M18.2M25.3M33.2M
 
 
 
 
 
Shares To Calculate EPS Diluted16.2M18.2M25.3M33.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.12-$1.34-$0.78-$0.90
 
 
 
 
 
EPS Diluted-$1.12-$1.34-$0.79-$0.90